首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1702123

2025 年至 2033 年儿科疫苗市场报告，按类型（多价、单价）、技术（结合疫苗、减毒活疫苗、灭活疫苗、次单位疫苗、类毒素疫苗及其他）、应用（传染病、癌症、过敏症及其他）和地区划分

Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2025-2033

出版日期: 2025年04月01日 | 出版商:

IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024年全球儿科疫苗市场规模达397亿美元。展望未来， IMARC Group预计到2033年市场规模将达到727亿美元，2025-2033年期间的成长率（CAGR）为6.89%。疫苗接种计划的不断实施、对联合疫苗的日益关注以及製药公司和医疗保健组织之间为加快疫苗的开发和分发而不断加强的合作是推动市场发展的一些主要因素。

儿童疫苗是一种刺激免疫系统辨识和对抗特定传染源（如细菌或病毒）的药物製剂。它们由病原体的弱化或灭活形式或病原体的成分组成，促使免疫系统针对目标疾病产生防御机制。它们可以预防麻疹、小儿麻痹、百日咳、肝炎和流感。在批准使用之前，它们要经过严格的测试和评估，以确保其安全性。它们可以防止可能导致儿童严重併发症或死亡的疾病传播。

目前，儿童中各种传染性和潜在危及生命的疾病（如小儿麻痹、结核病和疟疾）的发病率不断上升，推动市场的成长。除此之外，世界各国政府也越来越采取倡议，为儿童接种可预防疾病的疫苗，也促进了市场的成长。此外，疫苗储存和分发方法的技术不断进步，改善了医疗基础设施欠发达地区的供应链，为市场前景提供了良好的前景。除此之外，製药公司和医疗保健组织之间日益加强的合作，加速了疫苗的研发和分发，也支持了市场的成长。此外，世界各地为改善医疗服务而不断增建的诊所和医院也促进了市场的成长。

儿科疫苗市场趋势/驱动因素：

疫苗接种计划的开展日益加强

疫苗接种计划的持续实施显着促进了儿科疫苗市场的发展。这些疫苗接种措施得到了政府和非政府组织的支持，在保障儿童的健康和福祉方面发挥关键作用。随着越来越多的儿童接受各种疾病的必要免疫接种，儿童疫苗的需求也随之增加。此外，以预防疾病为重点的疫苗接种计划正在降低儿童目标疾病的发生率。这进而减轻了医疗保健系统和家庭的负担，从而提高了儿童及其照顾者的整体生活品质。此外，家长和医疗保健提供者对免疫接种重要性的认识不断提高，疫苗接种率也在上升。

越来越关注联合疫苗

对联合疫苗的高度重视促进了儿科疫苗市场的积极发展。联合疫苗透过单一配方提供对多种疾病的保护，为免疫接种提供了一种策略方法。这种方法简化了医疗保健提供者、护理人员和儿童的疫苗接种过程，从而提高了依从性和疫苗覆盖率。此外，联合疫苗解决了疫苗犹豫和漏接种的可能性的问题。由于儿童只需注射一次疫苗即可预防多种疾病，因此疫苗接种的负担显着减轻。这鼓励父母遵守建议的疫苗接种时间表，并有助于实现更高的全面免疫覆盖率。

新型疫苗研发不断涌现

新型疫苗的持续发展在推动儿科疫苗市场积极成长方面发挥关键作用。专门针对儿童健康需求的新型疫苗的出现有助于加强疾病预防、改善公共卫生结果并扩大市场机会。新型疫苗的开发也反映了疫苗技术和研究的进步。基因组学和生物资讯学等尖端研究方法使科学家能够更快、更准确地识别潜在的疫苗候选物。这种加速的发现步伐正在创造出有效且符合不断变化的流行病学情况的疫苗。此外，新型疫苗的持续发展正在刺激公共卫生组织、研究机构和疫苗製造商之间的合作。这些合作关係有助于及时推出新疫苗，并确保其有效分发给儿科族群。

市场结构
关键参与者
关键参与者简介
- Abbott Laboratories
- Bio-Med Private Limited
- Daiichi Sankyo Company Limited
- GSK plc
- Indian Immunologicals Limited (National Dairy Development Board)
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
- Panacea Biotec Limited
- Pfizer Inc.
- Sanofi SA
- Sinovac Biotech Ltd.

简介目录图表

Product Code: SR112025A6230

The global pediatric vaccines market size reached USD 39.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 72.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.89% during 2025-2033. The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.

Pediatric vaccines are medical preparations that stimulate the immune system to recognize and fight specific infectious agents, such as bacteria or viruses. They comprise weakened or inactivated forms of the pathogens, or components of the pathogens, which prompt the immune system to develop a defense mechanism against the targeted disease. They provide protection from measles, polio, pertussis (whooping cough), hepatitis, and influenza. They undergo rigorous testing and evaluation to ensure their safety before being approved for use. They prevent the spread of diseases that can cause severe complications or death in children.

At present, the increasing occurrence of various infectious and potentially life-threatening diseases, such as polio, tuberculosis (TB), and malaria among children, is impelling the growth of the market. Besides this, rising government initiatives around the world aimed at immunizing children against preventable diseases are contributing to the growth of the market. In addition, the growing technological advancements in vaccine storage and distribution methods for improving the supply chain in regions where medical infrastructure may be less developed are offering a favorable market outlook. Apart from this, increasing partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are supporting the growth of the market. Additionally, the rising construction of clinics and hospitals around the world to improve healthcare services is bolstering the growth of the market.

Pediatric Vaccines Market Trends/Drivers:

Growing conduction of vaccination programs

The increasing implementation of vaccination programs is notably bolstering the pediatric vaccines market. These vaccination initiatives, supported by governmental and non-governmental organizations, play a pivotal role in safeguarding the health and well-being of children. As more children receive essential immunizations against various diseases, the demand for pediatric vaccines experiences a proportional rise. Besides this, vaccination programs, with their focus on disease prevention, are decreasing the incidence of targeted illnesses among children. This subsequently translates into a reduced burden on healthcare systems and families, thereby enhancing the overall quality of life for children and their caregivers. Furthermore, the growing awareness among parents and healthcare providers about the importance of immunizations is rising the vaccine uptake rates.

Increasing focus on combination vaccines

The heightened emphasis on combination vaccines is contributing to the positive evolution of the pediatric vaccines market. Combination vaccines offer a strategic approach to immunization by providing protection against multiple diseases in a single formulation. This approach simplifies the vaccination process for healthcare providers, caregivers, and children alike, resulting in improved compliance and vaccine coverage rates. Moreover, combination vaccines address the challenges of vaccine hesitancy and the possibility of missed doses. As children receive protection against multiple diseases with one injection, the perceived burden of vaccinations is significantly reduced. This encourages parents to adhere to recommended vaccination schedules and contributes to achieving higher rates of full immunization coverage.

Rising development of novel vaccines

The increasing development of novel vaccines is playing a pivotal role in driving positive growth within the pediatric vaccines market. The emergence of new vaccines tailored specifically for the health needs of children contributes to enhanced disease prevention, improved public health outcomes, and expanded market opportunities. The development of novel vaccines also reflects advancements in vaccine technology and research. Cutting-edge research methodologies, such as genomics and bioinformatics, enable scientists to identify potential vaccine candidates more rapidly and accurately. This accelerated pace of discovery is creating vaccines that are efficacious and align with the evolving epidemiological landscape. Furthermore, the rising development of novel vaccines is stimulating collaboration between public health organizations, research institutions, and vaccine manufacturers. These partnerships facilitate the timely introduction of new vaccines and ensure their efficient distribution to the pediatric population.

Pediatric Vaccines Industry Segmentation:

Breakup by Type:

Multivalent
Monovalent

Multivalent dominates the market

Multivalent pediatric vaccines refer to immunization formulations that provide protection against multiple diseases through a single vaccine injection. These vaccines are designed to target two or more different disease-causing agents, such as viruses or bacteria, in a single formulation. Multivalent pediatric vaccines streamline the vaccination process by offering protection against multiple diseases with a single injection. This eliminates the need for multiple shots, reducing discomfort for children and simplifying the vaccination schedule for healthcare providers and caregivers. Multivalent pediatric vaccines optimize healthcare resources by combining multiple vaccines into a single formulation. This can result in cost savings for healthcare systems and reduce the logistical challenges associated with administering separate vaccines.

Breakup by Technology:

Conjugate
Live Attenuated
Inactivated
Subunit
Toxoid
Others

Conjugate holds the largest share in the market

Conjugate vaccines are a type of immunization that enhances the immune response against certain bacteria that have a protective polysaccharide outer coating. These vaccines work by linking or conjugating the bacterial polysaccharides to a carrier protein, creating a complex that stimulates a stronger and more effective immune response, especially in young children whose immune systems might not respond well to polysaccharides alone. Conjugate vaccines not only protect vaccinated individuals but can also reduce the carriage of bacteria in the population. This indirectly limits the spread of bacteria among both vaccinated and unvaccinated individuals. Conjugate vaccines contribute to herd immunity, which is essential for the prevention of the spreading of various infectious diseases among unvaccinated individuals.

Breakup by Application:

Infectious Disease
Cancer
Allergy
Others

Pediatric vaccines play a crucial role in preventing infectious diseases among children. By providing immunity against harmful pathogens, vaccines contribute to the health and well-being of children and infants. These vaccines are carefully developed based on scientific examination and clinical trials to ensure their safety and effectiveness.

Pediatric vaccines for cancer aim to prevent certain types of cancers that primarily affect children. They target certain infections, such as human papillomavirus (HPV) and hepatitis B virus (HBV) and are known to increase the risk of developing cancer. Besides this, administering vaccines during childhood allows for early prevention of cancer-related infections. This early intervention aligns with a proactive health approach, reducing the risk of cancer development later in life.

Pediatric vaccines play a crucial role in preventing a range of allergies among children. By bolstering the response of the immune system, vaccines help mitigate the risk of developing allergies to common allergens like pollen, dust, and pet dander.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest pediatric vaccines market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region due to the rising investment in research operations for the development of various novel vaccines for the prevention of infectious and chronic diseases. Besides this, the increasing awareness among parents and caregivers about the importance of immunization is propelling the growth of the market. Apart from this, rising improvements in the healthcare infrastructure to provide quality treatment and other healthcare facilities to individuals are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the increasing occurrence of infectious diseases caused by various novel viruses. Besides this, rising initiatives taken by governing agencies and regulatory bodies to promote the significance of vaccination in children are bolstering the growth of the market.

Competitive Landscape:

Key market players are diligently focused on enhancing their business strategies by consistently investing in research operations to formulate innovative vaccines that cater to evolving healthcare needs. They are fostering collaborations with research institutions and regulatory bodies to ensure the safety and efficacy of their products. Leading companies are strengthening their supply chain management and distribution networks to ensure timely availability of vaccines. Furthermore, top industry players are actively engaging in educational initiatives to increase awareness about the importance of vaccination, fostering trust and credibility within the community. This concerted effort to innovate, collaborate, and educate showcases their commitment to advancing the field of pediatric vaccines and contributing to public health on a global scale.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories
Bio-Med Private Limited
Daiichi Sankyo Company Limited
GSK plc
Indian Immunologicals Limited (National Dairy Development Board)
Merck & Co. Inc.
Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
Panacea Biotec Limited
Pfizer Inc.
Sanofi S.A.
Sinovac Biotech Ltd.

Key Questions Answered in This Report

1.What was the size of the global pediatric vaccines market in 2024?
2.What is the expected growth rate of the global pediatric vaccines market during 2025-2033?
3.What are the key factors driving the global pediatric vaccines market?
4.What has been the impact of COVID-19 on the global pediatric vaccines market?
5.What is the breakup of the global pediatric vaccines market based on the type?
6.What is the breakup of the global pediatric vaccines market based on the technology?
7.What are the key regions in the global pediatric vaccines market?
8.Who are the key players/companies in the global pediatric vaccines market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Pediatric Vaccines Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Multivalent
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Monovalent
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Conjugate
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Live Attenuated
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Inactivated
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Subunit
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Toxoid
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Infectious Disease
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cancer
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Allergy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Bio-Med Private Limited
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Daiichi Sankyo Company Limited
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 GSK plc
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Merck & Co. Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 SWOT Analysis
- 14.3.8 Panacea Biotec Limited
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Pfizer Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Sanofi S.A.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Sinovac Biotech Ltd.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2024
Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2024
Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2024
Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2024
Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2024
Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Pediatric Vaccines Market: Competitive Structure
Table 7: Global: Pediatric Vaccines Market: Key Players

02-2729-4219

+886-2-2729-4219